摘要
静脉注射用免疫球蛋白(IVIG)在恶性血液肿瘤化疗、靶向治疗及造血干细胞移植中的应用越来越普遍,但国内外尚无儿童血液/肿瘤性疾病中IVIG应用的临床指南或共识。该共识基于儿童血液/肿瘤性疾病中IVIG应用的国内外研究进展而制定,对IVIG在儿童血液/肿瘤性疾病中的临床应用策略及其不良反应的防治提出具体建议。
Intravenous immunoglobulin(IVIG) has been widely used in chemotherapy for hematological malignancies, targeted therapy, and hematopoietic stem cell transplantation;however, there are still no available guidelines or consensus statements on the application of IVIG in pediatric hematological/neoplastic diseases at present in China and overseas. This consensus is developed based on the research advances in the application of IVIG in pediatric hematological/neoplastic diseases across the world and provides detailed recommendations for the clinical application of IVIG in pediatric hematological/neoplastic diseases and the prevention and treatment of related adverse reactions.
出处
《中国当代儿科杂志》
CAS
CSCD
北大核心
2021年第4期319-327,共9页
Chinese Journal of Contemporary Pediatrics
关键词
血液病
肿瘤性疾病
静脉注射用免疫球蛋白
专家共识
儿童
Hematological disease
Neoplastic disease
Intravenous immunoglobulin
Expert consensus
Child
